Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral: Vanier Canada Graduate Scholarships

University of Toronto

$150,000.00

Characterization of the genetic and micro-environmental heterogeneity of prostate cancer using genomics technologies

EF 2012-13

Résumé
Malignancy of the prostate is the most diagnosed cancer type in Canadian males and the third most deadly cancer in this population; however, effective methods for diagnosis, prognosis, and prediction of recurrence are yet undiscovered. A tumour is initiated by a small number of mutations in the DNA, the genetic material of the cell, and progress by creating more mutations which catastrophically transform the genome. In patients, cancer cells are not regulated by normal mechanisms and grow uninhibited, damaging the organ(s). Curing cancer is difficult because each cancer is genetically different and may contain multiple tumours with different behaviours; we term this genetic heterogeneity. We are specifically interested in the oxygen levels of tumours because low level of oxygen, called hypoxia, is responsible for enabling a tumour to resist chemotherapy and radiation therapy. My research objective is to find genes controlling tumour oxygen levels by studying the DNA sequences of tumours with hypoxia and comparing them to those of tumours without hypoxia. The project will utilize cutting-edge DNA sequencing machines and bioinformatics softwares to uncover specific genes responsible for this tumour behaviour. Ultimately, we hope to find genetic biomarkers that can be used in the clinic for improved diagnosis, prognosis, and treatment of patients. As a result, the study will benefit patients to receive the most optimized treatments and benefit clinicians to provide the most effective treatment.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
274455
Name
Kim Jaeseung
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Characterization of the genetic and micro-environmental heterogeneity of prostate cancer using genomics technologies
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Bioinformatics; Biomarker; Cancer Prognosis; Hypoxia; Mouse Xenograft; Prostate Cancer; Tumour Micro-Environment; Whole-Genome Sequencing
Abstract
Malignancy of the prostate is the most diagnosed cancer type in Canadian males and the third most deadly cancer in this population; however, effective methods for diagnosis, prognosis, and prediction of recurrence are yet undiscovered. A tumour is initiated by a small number of mutations in the DNA, the genetic material of the cell, and progress by creating more mutations which catastrophically transform the genome. In patients, cancer cells are not regulated by normal mechanisms and grow uninhibited, damaging the organ(s). Curing cancer is difficult because each cancer is genetically different and may contain multiple tumours with different behaviours; we term this genetic heterogeneity. We are specifically interested in the oxygen levels of tumours because low level of oxygen, called hypoxia, is responsible for enabling a tumour to resist chemotherapy and radiation therapy. My research objective is to find genes controlling tumour oxygen levels by studying the DNA sequences of tumours with hypoxia and comparing them to those of tumours without hypoxia. The project will utilize cutting-edge DNA sequencing machines and bioinformatics softwares to uncover specific genes responsible for this tumour behaviour. Ultimately, we hope to find genetic biomarkers that can be used in the clinic for improved diagnosis, prognosis, and treatment of patients. As a result, the study will benefit patients to receive the most optimized treatments and benefit clinicians to provide the most effective treatment.
Competitiondate
201211
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Kim, Jaeseung
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~